Episode 822: Conexeu Sciences ($CNXU): The Future of Regenerative Aesthetics

from Stocks To Watch · host Global One Media Pte. Ltd.

This interview is disseminated on behalf of Conexeu Sciences Inc.Conexeu Sciences (NASDAQ: CNXU) President and CEO Miles Harrison discusses how the company’s regenerative medicine platform could address the growing demand for tissue restoration driven by GLP-1 weight loss medications, extracellular matrix technology, multi-market strategy, and the future of bioregeneration.Learn more: https://www.conexeu.com/Watch the full YouTube interview here: https://youtu.be/FJUXvMrH5hUAnd follow us to stay updated: https://www.youtube.com/GlobalOneMedia

Episode metadata supplied by the publisher feed · Published May 27, 2026

Embed this episode

Attribution link and audio player

Ready to play

Episode 822: Conexeu Sciences ($CNXU): The Future of Regenerative Aesthetics

0:00 25:18

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Stocks To Watch?

This episode is 25 minutes long.

When was this Stocks To Watch episode published?

This episode was published on May 27, 2026.

Can I download this Stocks To Watch episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!